Rochester, New York, August 31, 2026 – Harter Secrest & Emery LLP, a full-service business law firm with offices throughout New York, recently represented Transcat, Inc. (Nasdaq: TRNS), a leading provider of accredited calibration services and test and measurement equipment, in a $12.8 million acquisition of privately-held Southeastern Biomedical Associates Incorporated, effective August 31, 2026. The acquisition complements Transcat’s existing biomedical business and advances its strategy of building scale in regulated, high cost-of-failure end markets, where accredited calibration is mission-critical to patient safety and regulatory compliance.
The Mergers and Acquisitions team advising Transcat was led by Phillip A. Delmont and Andrew J. Latona, with additional attorneys such as Diana R. Clarkson (Corporate), Margaret K. Rhoda (Securities and Capital Markets) and Karianne P. Blood (Real Estate) contributing to the representation of Transcat.
Transcat is focused on providing best-in-class services and products to highly regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities.
With top tier rankings by Best Law Firms® and Chambers and Partners, Our Mergers and Acquisitions team represents clients in connection with transactions ranging in value from several million- to multi-billion dollars. Clients include entrepreneurs, start-up companies and non-profit organizations, to middle-market and publicly traded corporations.